Evaluation of the QT effect of a combination of piperaquine and a novel anti‐malarial drug candidate OZ439, for the treatment of uncomplicated malaria-Reference-Cited by-同舟云学术

Evaluation of the QT effect of a combination of piperaquine and a novel anti‐malarial drug candidate OZ439, for the treatment of uncomplicated malaria

Published:2015-07-14 Issue:4 Volume:80 Page:706-715
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Darpo Borje¹,Ferber Georg²,Siegl Peter³,Laurijssens Bart⁴,Macintyre Fiona⁵,Toovey Stephen⁶,Duparc Stephan⁵

Affiliation:

1. Associate Professor of Cardiology, Karolinska Institute, Division of Cardiovascular Medicine, Department of Clinical Sciences Danderyd's Hospital Stockholm Sweden

2. Georg Ferber Statistical Consultant Riehen Switzerland

3. Siegl Pharma Consulting LLC Blue Bell Pennsylvania USA

4. BEL Pharm Consulting Chambonas France

5. Medicines for Malaria Venture Geneva Switzerland

6. Pegasus Research London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12680

Reference28 articles.